Ohio State oncologist Ning Jin and many colleagues are alarmed by a growing number of patients in their 30s and 40s presenting with late-stage cancers of the lower digestive tract. These younger patients not only appear decades earlier than the historic norm, their tumors also often respond poorly: even with more aggressive chemotherapy or surgery, outcomes are not necessarily better. Colorectal cancer has become the leading cancer killer for people under 50, even as death rates fall in older groups.
While advances have made many cancers more treatable, colorectal cancer is becoming both more common and more lethal at younger ages. The cause of this generational shift is a major medical mystery, and researchers increasingly suspect the gut microbiome plays a central role. Patient advocates urge greater attention to symptoms and earlier diagnostic testing for those with family histories; routine screening generally begins at age 45 and is not widely covered before then.
A generational change
Genetics account for some cases: up to about one in five patients carry hereditary markers, such as mutations linked to Lynch syndrome, that raise colorectal cancer risk. But genetic factors explain roughly 20% of cases, leaving the majority unexplained. That points to environmental or lifestyle changes as likely contributors.
Dr. John Marshall, head of clinical research at Georgetown’s Lombardi Cancer Center, says the shift has been dramatic. When he began practicing more than 30 years ago he saw essentially no patients under 50 with colon cancer; now younger patients make up a substantial fraction of his clinic. He also notes a change in tumor location: more early-onset tumors are appearing lower in the tract, nearer the rectum. Taken together, these trends suggest something tied to recent generational changes is affecting disease patterns.
Potential culprits
Experts point to several candidate causes that may alter cancer risk through effects on the gut. Greater consumption of ultra-processed foods, widespread exposure to plastics and chemicals that can leach into food and water, and more sedentary lifestyles are among the suspected factors. The prevailing theory is that these influences change the composition and function of the gut microbiome—the diverse bacteria and microorganisms that live in and around the digestive tract.
Marshall likens the microbiome to soil: it is the interface through which our bodies incorporate what we eat. If that “soil” has been altered, it could create conditions that favor tumor development. Certain chemicals may strip away the gut’s protective mucus layer, which serves as a barrier to the contents of the digestive tract. Losing that mucus is like tearing holes in a fence: it can expose underlying tissue to irritation and inflammation. Jin notes that microbes and environmental chemicals can both contribute to DNA damage and to a leaky gut, which may promote cancer development.
Searching deeper
Evidence is mounting but the picture is complex. One study linked colibactin—a DNA-damaging toxin produced by some strains of E. coli and other bacteria—to colon cancer in younger patients. Yet studying microbiome interactions is difficult: the mouth, stomach, and different sections of the gut each have distinct chemistries and microbial communities, and those local conditions may differently influence tumor formation.
Researchers also lack reliable clinical tests to define a “healthy” microbiome or to determine when a microbiome is on a path toward disease. Isolating which exposures or microbial shifts trigger cancer, and when to intervene, remains a major challenge. Jin and others call for more controlled studies that can examine specific factors and mechanisms.
For now, clinicians emphasize vigilance: awareness of symptoms, attention to family history, and further research into how environmental and microbial factors combine to drive this troubling rise in colorectal cancers among younger people.